A phase 3, multi-center trial of oral, sustained-release fampridine (4-aminopyridine) in multiple sclerosis

被引：0
|
作者：
Goodman, Andrew
Schwid, Steven
Brown, Theodore
Krupp, Lauren
Schapiro, Randall
Marinucci, Lawrence
Cohen, Ron
Blight, Andrew
机构：
来源：
NEUROLOGY | 2007年 / 68卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A206 / A206
页数：1
相关论文
共 50 条
  • [41] Novel immediate/sustained-release formulation of acetaminophen-ibuprofen combination (Paxerol®) for severe nocturia associated with overactive bladder: A multi-center, randomized, double blinded, placebo-controlled, 4-arm trial
    Lee, King C.
    Rauscher, Frank
    Kaminesky, Jed
    Ryndin, Igor
    Xie, Lei
    Zhao, Yunzhu
    Khusid, Johnathan A.
    Weiss, Jeffrey P.
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 (02) : 740 - 748
  • [42] The Researching the Effectiveness of a nutraceuticaL Intervention for multiplE sclerosis-related Fatigue (RELIEF) Trial: a multi-center randomized controlled trial protocol
    Marx, W.
    Vukcevic, D.
    van der Mei, I.
    Christodoulou, J.
    Jacka, F.
    Fernandes, B.
    Taylor, B.
    Broadley, S.
    Lechner-Scott, J.
    Berk, M.
    Macdonell, R.
    Lucas, R.
    Nesbitt, C.
    Butzkeuven, H.
    Staskova, L.
    Ponsonby, A. L.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (03) : NP32 - NP32
  • [43] Effect of time of day on walking capacity and self-reported fatigue in persons with multiple sclerosis: a multi-center trial
    Feys, P.
    Gijbels, D.
    Romberg, A.
    Santoyo, C.
    Gebara, B.
    de Noordhout, B. Maertens
    Knuts, K.
    Bethoux, F.
    de Groot, V.
    Vaney, C.
    Dalgas, U.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (03) : 351 - 357
  • [44] Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial
    Ozakbas, Serkan
    Turkoglu, Recai
    Tamam, Yusuf
    Terzi, Murat
    Taskapilioglu, Ozlem
    Yucesan, Canan
    Baser, Hatice Limoncu
    Gencer, Mehmet
    Akil, Esref
    Sen, Sedat
    Turan, Omer Faruk
    Sorgun, Mine Hayriye
    Yigit, Pinar
    Turkes, Nevin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 22 : 70 - 76
  • [45] Haptic vs sensorimotor training in the treatment of upper limb dysfunction in multiple sclerosis: A multi-center, randomised controlled trial
    Solaro, Claudio
    Cattaneo, Davide
    Basteris, Angelo
    Carpinella, Ilaria
    De Luca, Alice
    Mueller, Margit
    Bertoni, Rita
    Ferrarin, Maurizio
    Sanguineti, Vittorio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 412
  • [46] Re: Novel Immediate/Sustained-Release Formulation of Acetaminophen-Ibuprofen Combination (Paxerol®) for Severe Nocturia Associated with Overactive Bladder: A Multi-Center, Randomized, Double Blinded, Placebo-Controlled, 4-Arm Trial
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2019, 202 (02): : 217 - 218
  • [47] THE EFFECTS OF 4-AMINOPYRIDINE IN MULTIPLE-SCLEROSIS PATIENTS - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, CONCENTRATION-CONTROLLED, CROSSOVER TRIAL
    BEVER, CT
    YOUNG, D
    ANDERSON, PA
    KRUMHOLZ, A
    CONWAY, K
    LESLIE, J
    EDDINGTON, N
    PLAISANCE, KI
    PANITCH, HS
    DHIBJALBUT, S
    FOSSLER, MJ
    DEVANE, J
    JOHNSON, KP
    NEUROLOGY, 1994, 44 (06) : 1054 - 1059
  • [48] Is multiple cross-calibration needed in a multi-center study?: The phase 3 Strontium Ranelate program
    Perron, C
    Tahintzi-Zawadynski, S
    Hans, D
    Barada, M
    Gumy, C
    Slosman, D
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S111 - S111
  • [49] Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report
    Arreola-Mora, C.
    Silva-Pereyra, J.
    Fernandez, T.
    Paredes-Cruz, M.
    Bertado-Cortes, B.
    Grijalva, I
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 117 - 124
  • [50] The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patients
    Koshino, Yoshifumi
    Bahk, Won-Myong
    Sakai, Hideaki
    Kobayashi, Takayuki
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1273 - 1280
12345